Hepatic Metabolomics and Plasma MicroRNA Analysis of Combinations of an ASK1 Inhibitor, an ACC Inhibitor, and an FXR Agonist in a Rat Choline-Deficient High Fat Diet Model Reveal Reductions in Oxidative Stress, Inflammation and Fibrosis

被引:0
|
作者
Bates, Jamie [1 ]
Sarkar, Nandita [1 ]
Ramirez, Ricardo [1 ]
Lopez, David [1 ]
Wong, Kari [2 ]
Hollenback, David [1 ]
Liu, Kathy [1 ]
Zagorska, Anna [1 ]
Budas, Grant [1 ]
Liles, John [1 ]
Brockett, Robert [1 ]
Newstrom, David [1 ]
Mikaelian, Igor [1 ]
Li, Li [1 ]
Xu, Ren [1 ]
Breckenridge, David [1 ]
机构
[1] Gilead Sci Inc, Res, Foster City, CA 94404 USA
[2] Metabolon, Morrisville, NC USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1265
引用
收藏
页码:733A / 733A
页数:1
相关论文
共 1 条
  • [1] Combinations of an acetyl CoA carboxylase inhibitor, FXR agonist and GLP-1R agonist inhibits fibrosis progression in the rat choline-deficient, L-amino acid defined, high-fat diet model of advanced fibrosis
    Vijayakumar, Archana
    Norlin, Jenny Egecioglu
    Petersen, Pia Steen
    Veidal, Sanne
    Feigh, Michael
    Trevaskis, James
    Latta, Markus Robert
    JOURNAL OF HEPATOLOGY, 2021, 75 : S399 - S400